Breast cancer management in the era of Covid-19; key issues, contemporary strategies, and future implications

AHMSU Prodhan, DZ Islam, SS Khandker… - … Cancer: Targets and …, 2023 - Taylor & Francis
During the COVID-19 pandemic, several priority diseases were not getting sufficient
attention. Whilst breast cancer is a fatal disease affecting millions worldwide, identification …

[HTML][HTML] The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran

S Kalantari, A Sadeghzadeh-Bazargan… - Medical Journal of the …, 2021 - ncbi.nlm.nih.gov
Background: The COVID-19 infection is a novel virus that mainly targets the respiratory
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …

新型冠状病毒肺炎与抗肿瘤药物治疗

胡夕春, 胡志皇, 王碧芸, 王佳蕾, 陶荣, 张剑… - 中国癌症 …, 2022 - china-oncology.com
新型冠状病毒感染的肺炎(corona virus disease 2019, COVID-19) 疫情仍严重影响着世界各国
的医疗卫生体系, 而恶性肿瘤患者由于较低的免疫功能状态及更多的风险暴露, 影响更甚 …

COVID-19 and systemic anti-cancer therapy

HU Xichun, HU Zhihuang, W Biyun, W Jialei… - China …, 2022 - china-oncology.com
The corona virus disease 2019 (COVID-19) pandemic continues to severely impact
healthcare systems around the world, and patients with cancer are even worse affected …

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

L Garrigos, C Saura, C Martinez-Vila… - Therapeutic …, 2021 - journals.sagepub.com
Background: Cancer patients are at higher risk of COVID-19 complications and mortality
than the rest of the population. Breast cancer patients seem to have better prognosis when …

Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates

MA Youssef, SS Panda, DR Aboshouk… - …, 2022 - Wiley Online Library
Di [(E)‐arylidene]‐1‐[3‐(4‐methylpiperazin‐1‐yl) alkyl] piperidin‐4‐ones 7 a− k were
synthesized through dehydrohalogenation of 1‐(2‐chloroacyl) piperidin‐4‐ones 5 a− k with …

Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony‐stimulating factor following chemotherapy: Triangulation of …

Y Wang, W Cai, P He, Q Cai, J Huang… - … Journal of Cancer, 2024 - Wiley Online Library
Recombinant human granulocyte colony‐stimulating factor (G‐CSF) administration in
patients with cancer and coronavirus disease (COVID‐19) remains controversial. Concerns …

Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer

M Maki, R Takada, A Taniguchi, N Nomura… - … Health Care and …, 2022 - Springer
Background COVID-19 has become a significant health threat and a primary healthcare
concern among the most vulnerable patients with cancer. Patients with COVID-19 who have …

[HTML][HTML] Breast Cancer Survivors and COVID-19: Prevalence and Risk of Severe Disease in a Screening Study

V Zangouri, A Ranjbar, F Homapour… - Medical Journal of the …, 2023 - ncbi.nlm.nih.gov
Background Determining the risk of severe course coronavirus disease 2019 (COVID-19)
and its related factors in survivors of common cancers such as breast cancer is important …

乳腺癌合并新型冠状病毒肺炎感染患者的抗肿瘤合理化诊疗方案探讨

张郁瑭, 金奕婕, 张凤春, 徐迎春 - 上海交通大学学报(医学版), 2022 - xuebao.shsmu.edu.cn
新型冠状病毒肺炎(coronavirus disease 2019, COVID-19) 作为一种新发的急性呼吸道传染病,
目前已成为全球性重大公共卫生事件. 在COVID-19 流行期间, 与健康人群相比 …